Company Arch Biopartners Inc. Other OTC
Equities
ACHFF
CA03938C1041
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Technologies
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Muruve
FOU | Founder | - | 04/83/04 |
Richard Muruve
FOU | Founder | - | 04/83/04 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 01/10/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 07/10/07 |
Richard Muruve
FOU | Founder | - | 04/83/04 |
Claude Allary
BRD | Director/Board Member | 69 | 01/14/01 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 01/10/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,850,633 | 51,265,123 ( 80.29 %) | 0 | 80.29 % |
Company contact information
![address Arch Biopartners Inc.(ACHFF)](https://cdn.zonebourse.com/static/address/425298.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+25.68% | 52.73B | |
+37.49% | 39B | |
-8.90% | 38.52B | |
+28.40% | 30.38B | |
-12.26% | 26.39B | |
+10.29% | 26.08B | |
+44.83% | 14.15B | |
+32.58% | 12.6B | |
-6.07% | 11.51B |